AFP and hepatocellular carcinoma: In the clinical application of hepatocellular carcinoma (HCC), traditional diagnostic methods such as serum AFP have limited specificity and sensitivity (4), and current data show that there is no single biomarker for the diagnosis of HCC, especially in the inchoate stage of development (5).